Plain-English translation of NCT06053320 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether combining two rehabilitation treatments can help stroke survivors recover better from spatial neglect—a condition where people have trouble noticing one side of their body or surroundings after a right-side stroke. Researchers will use prism adaptation therapy (special glasses that shift your view) combined with neuromuscular electrical stimulation (gentle electrical pulses to muscles) to see if together they improve how people notice space and walk. The study will first test these approaches in healthy volunteers, then compare the results in stroke survivors.
Spatial neglect affects more than half of people with right-hemisphere strokes and makes recovery harder, increases fall risk, and leads to longer hospital stays. Researchers want to understand whether combining these two proven therapies works better than either one alone to help stroke survivors regain their ability to notice their full surroundings and walk safely.
You likely qualify if…
You likely don't qualify if…
If you're a healthy volunteer, you'll visit the lab for sessions where you'll wear special prism glasses and receive electrical stimulation while doing tasks, and researchers will test how your brain responds using brain stimulation. If you're a stroke survivor, you'll participate in similar rehabilitation sessions combining the prism glasses and electrical stimulation tailored to your needs, with visits that include walking tests and measurements of your recovery. The study involves approximately 65 participants across all groups.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
United States
Sponsor
Emory University
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
Enrollment target
~65 participants
Started
April 2023
Primary completion
September 2026
Age range
18 Years – 90 Years
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Fisayo Aloba, PT, DPT
Emory University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.